{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-055075","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2022-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.129091+00:00","generated_at":"2026-06-23T11:45:38.236019+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ABVC BioPharma appoints Leeds Chow as CFO and Principal Accounting Officer effective Sept 4, 2022","bullets":["Leeds Chow, 34, previously Controller since March 2021, appointed CFO and Principal Accounting Officer on Sept 4, 2022.","Mr. Chow has over 12 years experience in audit and financing, including family office and Hong Kong IPO advisory roles.","He holds a BA in Business Economics with Accounting Emphasis from the University of California, Santa Barbara.","No departure of prior CFO was announced; the board determined the reappointment to be in the Company's best interests."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-055075","json":"https://secwatch.observer/filing/0001213900-22-055075.json","markdown":"https://secwatch.observer/filing/0001213900-22-055075.md","text":"https://secwatch.observer/filing/0001213900-22-055075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022055075/0001213900-22-055075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022055075/ea165554-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T11:45:38.236019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d64ef7af46","claim":"Leeds Chow was appointed as Chief Financial Officer and Principal Accounting Officer at ABVC BIOPHARMA, INC..","evidence_excerpt":"the Board has determined that it is in the best interests of ABVC BIOPHARMA, INC. (the “ Company ”) to reappoint Leeds Chow, age 34, the Company’s Controller, as Chief Financial Officer and Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390022055075/0001213900-22-055075-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}